Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
YBGJ stock price ended at $0.02 on 木曜日, after rising 100.00%
On the latest trading day Mar 12, 2026, the stock price of YBGJ rose by 100.00%, climbing from $0.01 to $0.02. During the session, the stock saw a volatility of 100.00%, with prices oscillating between a daily low of $0.01 and a high of $0.02. Notably, trading volume dropped by 112 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 20.1K shares were traded, equating to a market value of approximately $3.4M.